Shahar Tsabari, M.D., presents at the 10th CEO Day

Berne, Switzerland (October 23, 2013)

Shahar Tsabari, M.D., presents Swiss Medendi within the pitching competition at the 10th CEO Day in Stade de Suisse in Berne, Switzerland.

About CEO Day

The CEO Day organized by CTI Invest is one of the leading events for entrepreneurs in Switzerland and allows young CEOs to learn from others and to meet potential business partners and investors. This is fostered within one-to-one meetings, pitching competitions and network sessions. For more information on the 10th CEO Day, please visit

About Swiss Medendi

Swiss Medendi SA is a Switzerland based start-up company offering a proprietary, cost-efficient and easy-to-use intravenous (IV) infusion device, the HC100, for safe administration of chemotherapeutics and other vesicant and irritant drugs – protecting patients’ veins and vessels from vesicant damages, and preventing patients from injuries and complications associated today with ports and catheters. Employing the HC100 will help hospitals to manage costs and enable doctors to focus more on their patients’ needs. For more information on Swiss Medendi, please visit


October 23, 2013